There have been 118 more reports of electronic cigarette users suffering seizures since the FDA first warned the public about the danger in April, bringing the total number of reported cases to 127 between 2010 and 2019.
Using data from the CARDIA study, it has been shown that smoking in early adulthood to midlife is associated with midlife cognitive impairment, and that quitting smoking, even in midlife, can have cognitive benefits.
Smoking may be related to the severity of obstructive sleep apnea.
Cigarette smoking is associated with more severe multiple sclerosis disease course with lower lifetime cigarette smoking load and smoking cessation having no significant effect on disease severity.
Varenicline and bupropion may be safer to use than smokers often realize.
Smoking has been linked to advanced brain atrophy in individuals with multiple sclerosis.
Research has shown a confounding link between nicotine and reduced risk of Parkinson’s disease.
Those with only a high-school degree and non-whites also were far more likely to smoke than better-educated adults and/or whites.
Adjustment for smoking attenuated the risk for all strokes, ischemic, and hemorrhagic strokes.
Compared to those who continued smoking, those who stopped experienced a significant decline in the rate of brain volume loss.
